281 related articles for article (PubMed ID: 17067352)
1. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study.
Anton RF; Youngblood M
Alcohol Clin Exp Res; 2006 Nov; 30(11):1878-83. PubMed ID: 17067352
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment.
Rukstalis MR; Lynch KG; Oslin DW; Pettinati HM; Anderson SM; Volpicelli JR; Anton RF
Alcohol Clin Exp Res; 2002 Oct; 26(10):1539-44. PubMed ID: 12394287
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlations with carbohydrate-deficient transferrin levels in women with alcoholism.
Oslin DW; Pettinati HM; Luck G; Semwanga A; Cnaan A; O'Brien CP
Alcohol Clin Exp Res; 1998 Dec; 22(9):1981-5. PubMed ID: 9884141
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate-deficient transferrin: an investigative biochemical marker of heavy alcohol consumption.
Saini RS; Pettinati HM; Semwanga AE; O'Brien CP
Psychopharmacol Bull; 1997; 33(1):171-5. PubMed ID: 9133771
[TBL] [Abstract][Full Text] [Related]
5. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment.
Baros AM; Wright TM; Latham PK; Miller PM; Anton RF
Alcohol Alcohol; 2008; 43(2):192-7. PubMed ID: 18039674
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
Anton RF; Lieber C; Tabakoff B;
Alcohol Clin Exp Res; 2002 Aug; 26(8):1215-22. PubMed ID: 12198396
[TBL] [Abstract][Full Text] [Related]
7. [Carbohydrate deficient transferrin, gammaglutamyl transferase and mean corpuscular volume in the evaluation of recent alcohol intake in excessive drinkers].
Glasinovic JC; Lobos X; Scrivanti M; Severín MC; Quiroga T; Moncada C
Rev Med Chil; 2001 Apr; 129(4):375-81. PubMed ID: 11413989
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
Hietala J; Koivisto H; Anttila P; Niemelä O
Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
[TBL] [Abstract][Full Text] [Related]
9. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
10. Analysis of carbohydrate deficient transferrin serum levels during abstinence.
Ridinger M; Köhl P; Gäbele E; Wodarz N; Schmitz G; Kiefer P; Hellerbrand C
Exp Mol Pathol; 2012 Feb; 92(1):50-3. PubMed ID: 22032939
[TBL] [Abstract][Full Text] [Related]
11. Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study.
Myrick H; Henderson S; Anton RF
Alcohol Clin Exp Res; 2001 Sep; 25(9):1330-4. PubMed ID: 11584153
[TBL] [Abstract][Full Text] [Related]
12. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
13. Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.
Bråthen G; Bjerve KS; Brodtkorb E; Helde G; Bovim G
Alcohol Clin Exp Res; 2001 Jan; 25(1):46-53. PubMed ID: 11198714
[TBL] [Abstract][Full Text] [Related]
14. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism.
Menninger JA; Barón AE; Conigrave KM; Whitfield JB; Saunders JB; Helander A; Eriksson CJ; Grant B; Hoffman PL; Tabakoff B
Alcohol Clin Exp Res; 2000 Jun; 24(6):810-21. PubMed ID: 10888069
[TBL] [Abstract][Full Text] [Related]
15. Impact of motivational changes on drinking outcomes in pharmacobehavioral treatment for alcohol dependence.
Penberthy JK; Hook JN; Vaughan MD; Davis DE; Wagley JN; Diclemente CC; Johnson BA
Alcohol Clin Exp Res; 2011 Sep; 35(9):1694-704. PubMed ID: 21676008
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers.
Bergström JP; Helander A
Alcohol Alcohol; 2008; 43(4):436-41. PubMed ID: 18411243
[TBL] [Abstract][Full Text] [Related]
17. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.
Conigrave KM; Degenhardt LJ; Whitfield JB; Saunders JB; Helander A; Tabakoff B;
Alcohol Clin Exp Res; 2002 Mar; 26(3):332-9. PubMed ID: 11923585
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of carbohydrate-deficient transferrin (CDT) in the assessment of abuse and abstinence in chronic alcoholism].
Avivar Falcón I; Rubio Rubio JM; Leal Luna A; González Vilches J; del Trigo Espinosa MA
An Med Interna; 2000 Nov; 17(11):572-5. PubMed ID: 11322028
[TBL] [Abstract][Full Text] [Related]
19. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker.
Bergström JP; Helander A
Clin Chim Acta; 2008 Feb; 388(1-2):59-67. PubMed ID: 17980706
[TBL] [Abstract][Full Text] [Related]
20. Does participation in an alcohol administration study increase risk for excessive drinking?
Pratt WM; Davidson D
Alcohol; 2005 Nov; 37(3):135-41. PubMed ID: 16713501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
